| Product Code: ETC12345477 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China HCV Direct Acting Antiviral Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China HCV Direct Acting Antiviral Market Revenues & Volume, 2021 & 2031F |
3.3 China HCV Direct Acting Antiviral Market - Industry Life Cycle |
3.4 China HCV Direct Acting Antiviral Market - Porter's Five Forces |
3.5 China HCV Direct Acting Antiviral Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China HCV Direct Acting Antiviral Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China HCV Direct Acting Antiviral Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China HCV Direct Acting Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Hepatitis C virus (HCV) in China |
4.2.2 Growing awareness and screening programs for HCV |
4.2.3 Favorable government initiatives and funding for HCV treatment |
4.2.4 Technological advancements in direct-acting antiviral (DAA) therapies |
4.2.5 Rising healthcare expenditure and improving access to healthcare services in China |
4.3 Market Restraints |
4.3.1 High cost associated with DAA treatments |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited reimbursement policies for HCV treatments |
4.3.4 Lack of skilled healthcare professionals specialized in HCV treatment |
4.3.5 Competition from alternative treatment options for HCV |
5 China HCV Direct Acting Antiviral Market Trends |
6 China HCV Direct Acting Antiviral Market, By Types |
6.1 China HCV Direct Acting Antiviral Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China HCV Direct Acting Antiviral Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Antibody, 2021 - 2031F |
6.1.4 China HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Viral Load, 2021 - 2031F |
6.1.5 China HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Genotyping, 2021 - 2031F |
6.2 China HCV Direct Acting Antiviral Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China HCV Direct Acting Antiviral Market Revenues & Volume, By NS3/4A Protease Inhibitors, 2021 - 2031F |
6.2.3 China HCV Direct Acting Antiviral Market Revenues & Volume, By NS5A Polymerase Inhibitors, 2021 - 2031F |
6.2.4 China HCV Direct Acting Antiviral Market Revenues & Volume, By NS5B Polymerase Inhibitors, 2021 - 2031F |
6.2.5 China HCV Direct Acting Antiviral Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.3 China HCV Direct Acting Antiviral Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China HCV Direct Acting Antiviral Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
6.3.3 China HCV Direct Acting Antiviral Market Revenues & Volume, By Online Pharmacy, 2021 - 2031F |
6.3.4 China HCV Direct Acting Antiviral Market Revenues & Volume, By Retail Pharmacy, 2021 - 2031F |
7 China HCV Direct Acting Antiviral Market Import-Export Trade Statistics |
7.1 China HCV Direct Acting Antiviral Market Export to Major Countries |
7.2 China HCV Direct Acting Antiviral Market Imports from Major Countries |
8 China HCV Direct Acting Antiviral Market Key Performance Indicators |
8.1 Number of patients diagnosed with HCV annually in China |
8.2 Adoption rate of DAA therapies among HCV patients |
8.3 Success rate of DAA treatments in achieving sustained virologic response |
8.4 Patient adherence and completion rates of DAA treatment regimens |
8.5 Number of clinical trials and research studies focused on improving HCV treatment outcomes |
9 China HCV Direct Acting Antiviral Market - Opportunity Assessment |
9.1 China HCV Direct Acting Antiviral Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China HCV Direct Acting Antiviral Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China HCV Direct Acting Antiviral Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China HCV Direct Acting Antiviral Market - Competitive Landscape |
10.1 China HCV Direct Acting Antiviral Market Revenue Share, By Companies, 2024 |
10.2 China HCV Direct Acting Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here